Sale!

Rickettsia Antibody Panel Test

Original price was: 4,160 د.إ.Current price is: 3,740 د.إ.

-10%

The Rickettsia Antibody Panel Test is a diagnostic tool used to detect the presence of antibodies against Rickettsia bacteria in the blood. This test is crucial for diagnosing infections caused by Rickettsia, a genus of bacteria that is primarily transmitted to humans through the bites of infected ticks, fleas, and lice. These infections can lead to a range of illnesses, including Rocky Mountain spotted fever, typhus, and scrub typhus, among others. Early detection and treatment are vital for preventing complications associated with these diseases.

The test is performed by collecting a blood sample from the patient, which is then analyzed for the presence of specific antibodies that the body produces in response to a Rickettsia infection. The presence of these antibodies indicates a current or past infection.

In the United Arab Emirates, the Rickettsia Antibody Panel Test is available at DNA Labs UAE, a reputable laboratory known for its advanced diagnostic services. The cost of the test at DNA Labs UAE is 3740 AED. This price reflects the comprehensive nature of the panel, which can detect various strains of Rickettsia, and the specialized techniques used to ensure accurate results. Patients seeking this test can expect professional service and reliable results, aiding in the timely diagnosis and treatment of Rickettsia infections.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RICKETTSIA ANTIBODY PANEL Test

Test Cost: AED 3740.0

Are you experiencing symptoms that could be related to Rickettsia bacteria? DNA Labs UAE offers the Rickettsia Antibody Panel Test to help diagnose and monitor Rickettsia-related diseases. This blood test detects antibodies against Rickettsia bacteria in your body, providing valuable information for your healthcare provider.

Test Components

  • Rocky Mountain Spotted Fever IgG & IgM
  • Typhus Fever IgG & IgM

Price

AED 3740.0

Sample Condition

2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Duly filled Test Send Out Consent Form is mandatory.

Report Delivery

Sample by 7th of the month; Report after 2-3 weeks

Method

Immunofluorescence Assay

Test Type

Infections

Doctor

Physician

Test Department

OS

Pre Test Information

Duly filled Test Send Out Consent Form is mandatory.

Test Details

The Rickettsia antibody panel test is a blood test used to detect antibodies against Rickettsia bacteria in the body. Rickettsia bacteria are responsible for causing various diseases, such as Rocky Mountain spotted fever, typhus, and Q fever.

The antibody panel test is performed by taking a blood sample from the patient and analyzing it in a laboratory. The test measures the levels of antibodies, specifically IgM and IgG, produced by the immune system in response to Rickettsia infection. IgM antibodies are the first to be produced during an active infection, while IgG antibodies are produced later and can persist for a longer period of time.

By measuring the levels of these antibodies, the test can determine if a person has been recently infected or has had a past infection with Rickettsia bacteria. The Rickettsia antibody panel test can be helpful in diagnosing Rickettsia-related diseases, especially in cases where the symptoms are non-specific or when there is a need to confirm a suspected infection. It can also be used to monitor the effectiveness of treatment and to determine if a person has developed immunity to Rickettsia bacteria.

It is important to note that the Rickettsia antibody panel test is not a diagnostic test on its own. It is usually used in conjunction with other clinical findings, such as symptoms, medical history, and other laboratory tests, to make a definitive diagnosis. A healthcare provider will interpret the results of the test and provide appropriate recommendations and treatment options based on the findings.

Test Name RICKETTSIA ANTIBODY PANEL Test
Components *RockyMountainSpottedFever IgG&IgM*TyphusFever IgG&IgM
Price 3740.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Shiprefrigeratedorfrozen. Duly filled Test Send Out Consent Formis mandatory.
Report Delivery Sampleby7thofthemonth;Report after2??3weeks
Method Immunofluorescence Assay
Test type Infections
Doctor Physician
Test Department: OS
Pre Test Information Duly filled Test Send Out Consent Formis mandatory.
Test Details

The Rickettsia antibody panel test is a blood test used to detect antibodies against Rickettsia bacteria in the body. Rickettsia bacteria are responsible for causing various diseases, such as Rocky Mountain spotted fever, typhus, and Q fever.

The antibody panel test is performed by taking a blood sample from the patient and analyzing it in a laboratory. The test measures the levels of antibodies, specifically IgM and IgG, produced by the immune system in response to Rickettsia infection.

IgM antibodies are the first to be produced during an active infection, while IgG antibodies are produced later and can persist for a longer period of time. By measuring the levels of these antibodies, the test can determine if a person has been recently infected or has had a past infection with Rickettsia bacteria.

The Rickettsia antibody panel test can be helpful in diagnosing Rickettsia-related diseases, especially in cases where the symptoms are non-specific or when there is a need to confirm a suspected infection. It can also be used to monitor the effectiveness of treatment and to determine if a person has developed immunity to Rickettsia bacteria.

It is important to note that the Rickettsia antibody panel test is not a diagnostic test on its own. It is usually used in conjunction with other clinical findings, such as symptoms, medical history, and other laboratory tests, to make a definitive diagnosis. A healthcare provider will interpret the results of the test and provide appropriate recommendations and treatment options based on the findings.